Despite the fact that MHC I molecules were discovered more than 60 years ago [212,213,214], and that MHC is among the most central fields in basic and clinical immunology [215], there are still many unknowns regarding the modulation of MHC I molecules, both classic and non-classic, in tumor immunity. This evidence concerns the gene HLA-C and neoplasm.